Central Pacific Bank Trust Division Novartis Ag Transaction History
Central Pacific Bank Trust Division
- $839 Billion
- Q2 2024
A detailed history of Central Pacific Bank Trust Division transactions in Novartis Ag stock. As of the latest transaction made, Central Pacific Bank Trust Division holds 4,200 shares of NVS stock, worth $485,562. This represents 0.05% of its overall portfolio holdings.
Number of Shares
4,200
Previous 4,200
-0.0%
Holding current value
$485,562
Previous $403 Million
11.05%
% of portfolio
0.05%
Previous 0.05%
Shares
1 transactions
Others Institutions Holding NVS
# of Institutions
1,426Shares Held
138MCall Options Held
1.48MPut Options Held
1.54M-
Dodge & Cox San Francisco, CA12.2MShares$1.41 Billion0.82% of portfolio
-
Primecap Management CO Pasadena, CA12.2MShares$1.41 Billion0.95% of portfolio
-
Morgan Stanley New York, NY7.42MShares$857 Million0.06% of portfolio
-
Dimensional Fund Advisors LP Austin, TX7.41MShares$856 Million0.21% of portfolio
-
Loomis Sayles & CO L P5.95MShares$687 Million0.87% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $249B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...